Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
33.096 (93/281) |
4.91E-34 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
29.889 (81/271) |
8.44E-25 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
32.031 (82/256) |
1.61E-22 |
Serine/threonine-protein kinase 26 (STK26)
|
|
29.412 (75/255) |
3.48E-22 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
31.128 (80/257) |
5.19E-22 |
Protein kinase C delta (PRKCD)
|
|
28.685 (72/251) |
6.01E-22 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
28.674 (80/279) |
1.02E-21 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
32.530 (81/249) |
1.04E-21 |
NIMA-related kinase 6 (NEK6)
|
|
26.613 (66/248) |
1.83E-21 |
NIMA-related kinase 7 (NEK7)
|
|
25.610 (63/246) |
2.50E-21 |
Protein kinase C theta (PRKCQ)
|
|
27.434 (62/226) |
2.74E-21 |
Serine/threonine-protein kinase 24 (STK24)
|
|
28.627 (73/255) |
3.31E-21 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
31.518 (81/257) |
7.85E-21 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.745 (71/247) |
1.09E-20 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
28.340 (70/247) |
1.97E-20 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.340 (70/247) |
3.72E-20 |
Serine/threonine-protein kinase 25 (STK25)
|
|
33.149 (60/181) |
5.90E-20 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
28.981 (91/314) |
6.24E-20 |
Aurora kinase A (AURKA)
|
|
28.839 (77/267) |
6.76E-20 |
Death-associated protein kinase 3 (DAPK3)
|
|
31.982 (71/222) |
7.22E-20 |
BR serine/threonine kinase 1 (BRSK1)
|
|
30.120 (75/249) |
9.39E-20 |
BR serine/threonine kinase 2 (BRSK2)
|
|
29.572 (76/257) |
1.12E-19 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
33.503 (66/197) |
1.26E-19 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
28.340 (70/247) |
1.82E-19 |
SIK family kinase 3 (SIK3)
|
|
31.797 (69/217) |
4.01E-19 |
Polo-like kinase 4 (PLK4)
|
|
30.882 (63/204) |
4.38E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
28.315 (79/279) |
9.23E-19 |
Unc-51 like kinase 3 (ULK3)
|
|
28.352 (74/261) |
1.52E-18 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
31.163 (67/215) |
2.42E-18 |
Death-associated protein kinase 2 (DAPK2)
|
|
29.386 (67/228) |
3.49E-18 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
24.706 (63/255) |
3.70E-18 |
Omphalocele kinase 1 (NUAK1)
|
|
28.507 (63/221) |
5.39E-18 |
Serine/threonine-protein kinase 10 (STK10)
|
|
31.980 (63/197) |
7.21E-18 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
28.346 (72/254) |
8.23E-18 |
MEK kinase kinase 3 (MAP4K3)
|
|
30.729 (59/192) |
8.27E-18 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
31.683 (64/202) |
8.33E-18 |
MST-1 protein kinase (STK4)
|
|
26.210 (65/248) |
8.45E-18 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
29.964 (83/277) |
1.09E-17 |
Serine/threonine-protein kinase 3 (STK3)
|
|
26.613 (66/248) |
1.11E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
31.068 (64/206) |
1.14E-17 |
Aurora kinase C (AURKC)
|
|
27.037 (73/270) |
1.31E-17 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
29.808 (62/208) |
1.41E-17 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
29.249 (74/253) |
1.59E-17 |
Salt-inducible kinase 2 (SIK2)
|
|
28.571 (70/245) |
1.76E-17 |
Cyclin-dependent kinase 3 (CDK3)
|
|
29.167 (70/240) |
2.26E-17 |
Ste-20-related kinase (STK39)
|
|
27.240 (76/279) |
3.20E-17 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
26.766 (72/269) |
3.30E-17 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
26.415 (70/265) |
3.32E-17 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
28.986 (60/207) |
3.56E-17 |
Protein kinase C beta (PRKCB)
|
|
30.000 (60/200) |
4.20E-17 |
TAO kinase 3 (TAOK3)
|
|
27.431 (79/288) |
4.57E-17 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
36.250 (58/160) |
5.28E-17 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
30.688 (58/189) |
5.33E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
26.357 (68/258) |
6.04E-17 |
Myosin-IIIa (MYO3A)
|
|
26.792 (71/265) |
6.38E-17 |
MEK kinase kinase 2 (MAP4K2)
|
|
31.720 (59/186) |
8.17E-17 |
Cyclin-dependent kinase 15 (CDK15)
|
|
27.869 (68/244) |
8.26E-17 |
ERK activator kinase 5 (MAP2K5)
|
|
26.740 (73/273) |
8.56E-17 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
31.313 (62/198) |
1.02E-16 |
Cyclin-dependent kinase 1 (CDK1)
|
|
30.392 (62/204) |
1.20E-16 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
27.273 (54/198) |
1.43E-16 |
Cyclin-dependent kinase 14 (CDK14)
|
|
28.302 (60/212) |
1.76E-16 |
Doublecortin-like kinase 1 (DCLK1)
|
|
29.817 (65/218) |
2.32E-16 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
27.197 (65/239) |
2.35E-16 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
27.500 (55/200) |
2.60E-16 |
Protein kinase C alpha (PRKCA)
|
|
28.500 (57/200) |
2.65E-16 |
Serine/threonine-protein kinase 33 (STK33)
|
|
27.511 (63/229) |
2.98E-16 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
31.100 (65/209) |
3.08E-16 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
29.204 (66/226) |
3.17E-16 |
TAO kinase 1 (TAOK1)
|
|
26.007 (71/273) |
3.32E-16 |
Death-associated protein kinase 1 (DAPK1)
|
|
32.948 (57/173) |
3.71E-16 |
Cyclin-dependent kinase 5 (CDK5)
|
|
27.500 (66/240) |
3.75E-16 |
NIMA-related kinase 2 (NEK2)
|
|
24.231 (63/260) |
6.93E-16 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
30.137 (66/219) |
7.73E-16 |
Fused homolog (STK36)
|
|
28.141 (56/199) |
8.18E-16 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
29.787 (56/188) |
9.49E-16 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
26.596 (50/188) |
1.06E-15 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
22.476 (69/307) |
1.11E-15 |
MEK kinase kinase 4 (MAP4K4)
|
|
30.808 (61/198) |
1.34E-15 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
30.244 (62/205) |
1.81E-15 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
23.622 (60/254) |
1.83E-15 |
Misshapen-like kinase 1 (MINK1)
|
|
29.703 (60/202) |
2.01E-15 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
30.288 (63/208) |
2.70E-15 |
Cyclin-dependent kinase 2 (CDK2)
|
|
26.400 (66/250) |
4.54E-15 |
Cyclin-dependent kinase 7 (CDK7)
|
|
29.744 (58/195) |
6.35E-15 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
29.148 (65/223) |
6.60E-15 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
27.311 (65/238) |
6.61E-15 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
30.303 (60/198) |
7.72E-15 |
Cyclin-dependent kinase 12 (CDK12)
|
|
31.100 (65/209) |
7.73E-15 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
26.829 (66/246) |
8.14E-15 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
26.568 (72/271) |
8.25E-15 |
Protein kinase C eta type (PRKCH)
|
|
28.713 (58/202) |
9.09E-15 |
Cyclin-dependent kinase 6 (CDK6)
|
|
27.317 (56/205) |
1.03E-14 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
25.385 (66/260) |
1.11E-14 |
ERK activator kinase 1 (MEK1)
|
|
31.472 (62/197) |
1.19E-14 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
29.384 (62/211) |
1.22E-14 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
28.326 (66/233) |
1.45E-14 |
Doublecortin-like kinase 3 (DCLK3)
|
|
26.577 (59/222) |
1.85E-14 |
Myosin light kinase (MYLK)
|
|
27.000 (54/200) |
2.07E-14 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
28.000 (56/200) |
2.91E-14 |
CaM-kinase IV kinase (CAMKK1)
|
|
31.902 (52/163) |
3.33E-14 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
28.571 (56/196) |
3.50E-14 |
Cyclin-dependent kinase 9 (CDK9)
|
|
29.557 (60/203) |
3.65E-14 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
29.412 (65/221) |
3.68E-14 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
27.984 (68/243) |
4.24E-14 |
Protein kinase C epsilon (PRKCE)
|
|
28.205 (55/195) |
4.54E-14 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
29.808 (62/208) |
4.77E-14 |
Cyclin-dependent kinase 13 (CDK13)
|
|
29.048 (61/210) |
4.92E-14 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
26.641 (69/259) |
5.03E-14 |
Polo-like kinase 2 (PLK2)
|
|
26.070 (67/257) |
5.23E-14 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
26.230 (64/244) |
7.33E-14 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
30.583 (63/206) |
7.69E-14 |
Cyclin-dependent kinase 16 (CDK16)
|
|
23.932 (56/234) |
8.11E-14 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
29.064 (59/203) |
9.68E-14 |
ERK activator kinase 2 (MEK2)
|
|
30.964 (61/197) |
9.83E-14 |
Testis-specific serine kinase 2 (TSSK2)
|
|
29.412 (65/221) |
1.23E-13 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
27.799 (72/259) |
1.26E-13 |
Cyclin-dependent kinase 4 (CDK4)
|
|
29.327 (61/208) |
1.29E-13 |
Cyclin-dependent kinase 17 (CDK17)
|
|
26.238 (53/202) |
1.34E-13 |
MEK kinase kinase 1 (MAP4K1)
|
|
31.282 (61/195) |
1.37E-13 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
27.320 (53/194) |
1.59E-13 |
MAP kinase p38 (MAPK12)
|
|
30.303 (60/198) |
1.60E-13 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
27.273 (75/275) |
2.25E-13 |
Protein kinase N2 (PKN2)
|
|
24.825 (71/286) |
2.50E-13 |
PAK-1 protein kinase (PAK1)
|
|
27.778 (55/198) |
2.81E-13 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
30.612 (60/196) |
2.84E-13 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
28.641 (59/206) |
2.89E-13 |
Protein kinase N3 (PKN3)
|
|
29.200 (73/250) |
2.90E-13 |
Protein kinase N1 (PKN1)
|
|
26.715 (74/277) |
3.04E-13 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
26.172 (67/256) |
3.09E-13 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
27.919 (55/197) |
3.30E-13 |
PAK-4 protein kinase (PAK4)
|
|
29.293 (58/198) |
3.79E-13 |
Cyclin-dependent kinase 18 (CDK18)
|
|
25.500 (51/200) |
5.00E-13 |
Citron Rho-interacting kinase (CIT)
|
|
28.837 (62/215) |
5.11E-13 |
PAK-2 protein kinase (PAK2)
|
|
27.411 (54/197) |
5.52E-13 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
25.854 (53/205) |
5.55E-13 |
Myosin-IIIb (MYO3B)
|
|
29.902 (61/204) |
5.57E-13 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
26.481 (76/287) |
5.86E-13 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
26.126 (58/222) |
5.88E-13 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
24.837 (76/306) |
6.91E-13 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
29.612 (61/206) |
9.30E-13 |
Myosin light chain kinase 3 (MYLK3)
|
|
27.189 (59/217) |
1.02E-12 |
Myosin light chain kinase 2 (MYLK2)
|
|
25.366 (52/205) |
1.08E-12 |
Doublecortin-like kinase 2 (DCLK2)
|
|
25.688 (56/218) |
1.11E-12 |
Stress-activated protein kinase 2b (p38 beta)
|
|
28.986 (60/207) |
1.14E-12 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
26.977 (58/215) |
1.16E-12 |
NIMA-related kinase 1 (NEK1)
|
|
21.569 (55/255) |
1.20E-12 |
Cytoplasmic DRAK1 (STK17A)
|
|
27.230 (58/213) |
1.23E-12 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
25.000 (62/248) |
1.24E-12 |
Checkpoint kinase-1 (CHK1)
|
|
31.034 (63/203) |
1.34E-12 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
27.178 (78/287) |
1.48E-12 |
Rho-associated protein kinase 2 (ROCK2)
|
|
26.512 (57/215) |
1.55E-12 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
29.064 (59/203) |
1.60E-12 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
28.481 (45/158) |
1.61E-12 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
29.146 (58/199) |
1.69E-12 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
29.851 (60/201) |
1.69E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
25.974 (60/231) |
1.72E-12 |
Protein kinase D (PRKD1)
|
|
26.906 (60/223) |
1.98E-12 |
Polo-like kinase 1 (PLK1)
|
|
25.490 (65/255) |
2.35E-12 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
29.187 (61/209) |
2.38E-12 |
Protein kinase C gamma (PRKCG)
|
|
29.771 (39/131) |
2.54E-12 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.293 (58/198) |
2.76E-12 |
Protein kinase C iota (PRKCI)
|
|
25.962 (54/208) |
3.17E-12 |
Aurora kinase B (AURKB)
|
|
27.200 (68/250) |
3.19E-12 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
26.872 (61/227) |
3.38E-12 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
29.381 (57/194) |
3.39E-12 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
25.980 (53/204) |
3.42E-12 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
25.592 (54/211) |
3.53E-12 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
25.735 (70/272) |
3.87E-12 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
28.571 (58/203) |
3.94E-12 |
Protein kinase C zeta (PRKCZ)
|
|
24.883 (53/213) |
4.34E-12 |
Nik-related protein kinase (NRK)
|
|
27.132 (70/258) |
4.55E-12 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
27.451 (56/204) |
5.00E-12 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
26.222 (59/225) |
5.53E-12 |
Rho-associated protein kinase 1 (ROCK1)
|
|
26.638 (61/229) |
5.75E-12 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
25.592 (54/211) |
5.86E-12 |
Salt-inducible kinase 1 (SIK1)
|
|
26.316 (65/247) |
6.17E-12 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
26.316 (65/247) |
6.28E-12 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
24.537 (53/216) |
6.89E-12 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
27.962 (59/211) |
7.05E-12 |
Bone morphogenetic protein receptor (BMPR2)
|
|
25.503 (76/298) |
8.61E-12 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
31.250 (70/224) |
9.54E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
25.541 (59/231) |
9.82E-12 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
30.263 (46/152) |
1.14E-11 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
29.592 (58/196) |
1.21E-11 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
25.778 (58/225) |
1.38E-11 |
Protein kinase G2 (PRKG2)
|
|
26.050 (62/238) |
1.41E-11 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
28.079 (57/203) |
1.90E-11 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
23.267 (47/202) |
2.02E-11 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
31.250 (60/192) |
2.05E-11 |
Cyclin-dependent kinase 20 (CDK20)
|
|
28.685 (72/251) |
2.10E-11 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
27.477 (61/222) |
2.16E-11 |
ERK activator kinase 7 (MAP2K7)
|
|
28.358 (76/268) |
2.18E-11 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
28.230 (59/209) |
2.23E-11 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
27.354 (61/223) |
2.28E-11 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.728 (53/206) |
2.66E-11 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
29.524 (62/210) |
2.92E-11 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
26.056 (74/284) |
3.11E-11 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
29.064 (59/203) |
3.22E-11 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
23.938 (62/259) |
3.62E-11 |
Protein kinase G1 (PRKG1)
|
|
25.391 (65/256) |
3.81E-11 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
30.457 (60/197) |
4.15E-11 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
28.358 (57/201) |
4.73E-11 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
27.132 (70/258) |
5.34E-11 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
24.510 (50/204) |
5.80E-11 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
30.435 (63/207) |
6.01E-11 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
26.154 (51/195) |
9.24E-11 |
NF-kappa-B-activating kinase (TBK1)
|
|
26.638 (61/229) |
9.52E-11 |
Titin (TTN)
|
27.982 (61/218) |
1.10E-10 |
Activin receptor type IB (ACVR1B)
|
|
25.822 (55/213) |
1.29E-10 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
23.585 (50/212) |
1.60E-10 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
23.574 (62/263) |
1.70E-10 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
24.378 (49/201) |
1.72E-10 |
Cyclin-dependent kinase 10 (CDK10)
|
|
27.979 (54/193) |
1.90E-10 |
Serine/threonine-protein kinase NLK (NLK)
|
|
28.718 (56/195) |
2.19E-10 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
29.208 (59/202) |
2.23E-10 |
TGF-beta receptor type I (TGFBR1)
|
|
26.291 (56/213) |
2.60E-10 |
STE20-related kinase adapter protein beta (STRADB)
|
|
27.803 (62/223) |
2.71E-10 |
Serine/threonine-protein kinase MAK (MAK)
|
|
27.228 (55/202) |
2.90E-10 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
24.454 (56/229) |
2.94E-10 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
29.167 (63/216) |
3.13E-10 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
24.219 (62/256) |
3.68E-10 |
Casein kinase I delta (CSNK1D)
|
|
26.545 (73/275) |
4.59E-10 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
25.446 (57/224) |
4.75E-10 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
22.449 (55/245) |
5.09E-10 |
NDR1 protein kinase (STK38)
|
|
24.901 (63/253) |
5.45E-10 |
NDR2 protein kinase (STK38L)
|
|
23.887 (59/247) |
5.78E-10 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
23.970 (64/267) |
6.62E-10 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
31.658 (63/199) |
7.10E-10 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
26.627 (45/169) |
9.29E-10 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
22.458 (53/236) |
1.37E-09 |
Peripheral plasma membrane protein CASK (CASK)
|
|
26.860 (65/242) |
1.39E-09 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
24.731 (46/186) |
1.53E-09 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
26.437 (46/174) |
1.91E-09 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
24.706 (63/255) |
2.05E-09 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
29.487 (46/156) |
2.06E-09 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
25.221 (57/226) |
2.48E-09 |
Serine/threonine-protein kinase cot (COT)
|
|
24.055 (70/291) |
2.83E-09 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
27.778 (65/234) |
3.08E-09 |
Casein kinase I epsilon (CSNK1E)
|
|
26.182 (72/275) |
4.05E-09 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
25.641 (70/273) |
4.06E-09 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
26.744 (69/258) |
4.68E-09 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
24.299 (52/214) |
5.04E-09 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
25.664 (58/226) |
5.33E-09 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
24.576 (58/236) |
6.18E-09 |
Yet another novel kinase 2 (STK32B)
|
|
27.830 (59/212) |
1.63E-08 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
25.962 (54/208) |
1.64E-08 |
Serine/threonine-protein kinase 35 (STK35)
|
|
21.901 (53/242) |
1.69E-08 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
31.325 (52/166) |
1.83E-08 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
29.956 (68/227) |
1.97E-08 |
PDZ binding kinase (PBK)
|
|
27.586 (48/174) |
2.03E-08 |
Cyclin-dependent kinase 19 (CDK19)
|
|
24.272 (50/206) |
2.11E-08 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
30.622 (64/209) |
2.54E-08 |
Rhodopsin kinase GRK7 (GRK7)
|
|
25.373 (51/201) |
7.01E-08 |
TGF-beta-stimulated factor 1 (STK16)
|
|
25.116 (54/215) |
8.08E-08 |
Obscurin (OBSCN)
|
|
27.778 (50/180) |
8.08E-08 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
24.667 (74/300) |
1.10E-07 |
Triple functional domain protein (TRIO)
|
|
28.643 (57/199) |
1.81E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
23.256 (50/215) |
1.85E-07 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
25.260 (73/289) |
1.95E-07 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
23.963 (52/217) |
1.98E-07 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
23.963 (52/217) |
2.43E-07 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
30.120 (50/166) |
2.95E-07 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
23.316 (45/193) |
3.16E-07 |
Rhodopsin kinase GRK1 (GRK1)
|
|
22.275 (47/211) |
3.89E-07 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
29.474 (56/190) |
3.92E-07 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
24.324 (63/259) |
4.35E-07 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
30.769 (44/143) |
4.95E-07 |
Cyclin-dependent kinase 8 (CDK8)
|
|
24.272 (50/206) |
7.25E-07 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
25.806 (56/217) |
7.82E-07 |
PIM-3 protein kinase (PIM3)
|
|
24.907 (67/269) |
8.10E-07 |
Activin receptor type IIA (ACVR2A)
|
|
27.014 (57/211) |
1.27E-06 |
Large tumor suppressor homolog 2 (LATS2)
|
|
30.769 (44/143) |
1.69E-06 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
26.549 (60/226) |
1.90E-06 |
Membrane-associated kinase (PKMYT1)
|
|
25.728 (53/206) |
4.72E-06 |
Myotonin-protein kinase (DMPK)
|
|
25.346 (55/217) |
6.93E-06 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
25.547 (35/137) |
7.26E-06 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
28.125 (27/96) |
7.55E-06 |
Casein kinase I gamma-3 (CSNK1G3)
|
|
26.064 (49/188) |
9.80E-06 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
27.660 (39/141) |
9.84E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
26.577 (59/222) |
1.42E-05 |
Kalirin (KALRN)
|
|
26.000 (52/200) |
1.50E-05 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
21.074 (51/242) |
1.69E-05 |
Dual specificity protein kinase TTK (MPS1)
|
|
24.155 (50/207) |
2.79E-05 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
22.275 (47/211) |
2.89E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
25.253 (50/198) |
3.40E-05 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
25.926 (56/216) |
4.64E-05 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
27.551 (27/98) |
9.90E-05 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
25.592 (54/211) |
1.52E-04 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
26.222 (59/225) |
2.98E-04 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
27.673 (44/159) |
3.11E-04 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
21.101 (69/327) |
4.18E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.147 (57/218) |
4.29E-04 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
26.190 (55/210) |
4.29E-04 |
Casein kinase I isoform alpha-like (CSNK1A1L)
|
|
23.404 (66/282) |
4.44E-04 |
BMP-2-inducible protein kinase (BMP2K)
|
|
24.074 (52/216) |
5.54E-04 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
28.241 (61/216) |
5.82E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
26.570 (55/207) |
7.46E-04 |
N-terminal kinase-like protein (SCYL1)
|
|
25.714 (45/175) |
8.03E-04 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
23.204 (42/181) |
8.66E-04 |
Casein kinase I alpha (CSNK1A1)
|
|
23.050 (65/282) |
1.00E-03 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
28.571 (24/84) |
1.00E-03 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.570 (55/207) |
1.00E-03 |
Tribbles homolog 2 (TRIB2)
|
|
23.353 (39/167) |
2.00E-03 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
25.281 (45/178) |
4.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |